 Exhicon Global Development Ltd inks MoU with NIMA
Exhicon Global Development Ltd inks MoU with NIMA RateGain and FLYR Partner to Power Smarter Hotel Pricing with Integrated Rate Shopping
RateGain and FLYR Partner to Power Smarter Hotel Pricing with Integrated Rate Shopping JUSTO Secures ₹1,545+ Crore in New Mandates, Cumulative Portfolio Crosses ₹4,500 Crore
JUSTO Secures ₹1,545+ Crore in New Mandates, Cumulative Portfolio Crosses ₹4,500 Crore Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart 
              Dishman Pharmaceuticals & Chemicals Ltd has announced that the Board of Directors of the Company at its meeting held on July 18, 2007, inter alia, has allotted 25,32,555 equity shares of Rs 2/- each to the Company at a premium of Rs 170/- per equity share upon exercise of option of conversion by the FCCB holders for conversion of 0.50% Foreign Currency Convertible Bonds (FCCB) of the principal amount of US$ 10,000,000 into the equity shares of the Company.
Consequently, the paid-up equity share capital of the Company has increased from 73732607 equity shares of Rs 2/- each to 76265162 equity shares of Rs 2/- each.
The stock closed the day at Rs.335.05, up by Rs.4.60 or 1.39%. The stock hit an intraday high of Rs.336 and low of Rs.328. The total traded quantity was 10937 compared to 2 week average of 58428.